Jun 9, 2026 09:44AM

Mar 19, 2026 08:22AM

Mar 19, 2026 08:13AM

Mar 13, 2026 11:46AM

Mar 13, 2026 11:44AM

Jan 12, 2026 06:15AM

Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

Dec 17, 2025 04:40AM

Dec 16, 2025 09:55PM

Oct 30, 2025 07:27AM

Oct 24, 2025 05:24AM

Oct 23, 2025 08:11PM

Oct 21, 2025 02:00AM

Oct 21, 2025 02:00AM PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

Oct 17, 2025 07:01AM

Oct 17, 2025 07:00AM

Oct 1, 2025 10:00AM

Aug 29, 2025 12:08PM

Jul 23, 2025 12:08PM

Jul 17, 2025 07:01AM

Jul 17, 2025 07:00AM US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation

Jul 10, 2025 09:13AM

Jul 10, 2025 09:13AM

Jun 24, 2025 09:02AM

Jun 24, 2025 09:00AM

Jun 2, 2025 06:20AM

Jun 2, 2025 06:00AM

May 28, 2025 07:01AM Spero Therapeutics (SPRO) and GSK (GSK) Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy

May 28, 2025 07:00AM

May 22, 2025 04:16PM

May 22, 2025 04:15PM

May 22, 2025 03:26PM

May 22, 2025 02:56PM

Apr 16, 2025 04:57PM

Apr 16, 2025 04:57PM GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

Apr 9, 2025 05:00AM

Apr 6, 2025 08:33AM

Apr 4, 2025 01:04PM

Apr 1, 2025 02:41PM

Mar 31, 2025 08:59PM

Mar 31, 2025 04:00PM

Mar 31, 2025 02:35PM GSK DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GSK

Mar 29, 2025 06:26PM

Mar 29, 2025 07:32AM

Mar 28, 2025 06:26PM

Mar 27, 2025 06:21PM

Mar 27, 2025 11:28AM

Mar 26, 2025 06:16PM

Mar 25, 2025 06:15PM Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older

Mar 25, 2025 04:00PM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All